Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210 | 250 | 210 | 260 | 260 |
| Marketable Securities | 2,070 | 3,510 | 2,410 | 3,250 | 2,120 |
| Receivables | 1,530 | 420 | 1,490 | 740 | 2,120 |
| Other current assets | 90 | 110 | 150 | 90 | 70 |
| TOTAL | $3,900 | $4,290 | $4,260 | $4,340 | $4,570 |
| Non-Current Assets | |||||
| Investments And Advances | 200 | 200 | 400 | 410 | 420 |
| Other Non-Current Assets | 1,370 | 1,400 | 1,450 | 1,480 | 1,510 |
| TOTAL | $1,570 | $1,600 | $1,850 | $1,890 | $1,930 |
| Total Assets | $5,620 | $6,060 | $6,300 | $6,440 | $6,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 80 | 160 | 30 | 70 | 80 |
| Accrued Expenses | 1,450 | 1,790 | 1,790 | 1,660 | 1,580 |
| Other current liabilities | 0 | 290 | 290 | 290 | 290 |
| TOTAL | $1,540 | $2,260 | $2,120 | $2,020 | $1,950 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,540 | $2,260 | $2,120 | $2,020 | $1,950 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 60 | 60 | 60 |
| Retained earnings | -21,540 | -21,780 | -21,460 | -21,120 | -20,730 |
| Other shareholders' equity | -60 | -130 | -60 | -120 | -120 |
| TOTAL | $4,080 | $3,800 | $4,170 | $4,420 | $4,770 |
| Total Liabilities And Equity | $5,620 | $6,060 | $6,290 | $6,440 | $6,720 |